Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205918 · ClinicalTrials.gov registry record
Brain-Behavior Interactions in Tic Suppression
A clinical trial of Chronic Motor Tic Disorder and Chronic Vocal Tic Disorder, sponsored by University of Minnesota.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02205918: Completed study of Chronic Motor Tic Disorder and Chronic Vocal Tic Disorder, sponsored by University of Minnesota.
NCT02205918 is a study of Chronic Motor Tic Disorder and Chronic Vocal Tic Disorder that has completed, run by University of Minnesota. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02205918, a study of Chronic Motor Tic Disorder and Chronic Vocal Tic Disorder, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine how the brain and environment interact to influence children's ability to suppress tics using a medical technology called Transcranial Magnetic Stimulation (TMS).
Primary Outcome
Tics will be observed and counted
Conditions Studied
Interventions
- OTHER Active TMS
- OTHER Sham TMS
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2019-09-01 |
What the finished NCT02205918 record still lists
NCT02205918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 3 conditions, with Chronic Motor Tic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active TMS is the first listed.
NCT02205918 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02205918 about?
NCT02205918 is a clinical study titled "Brain-Behavior Interactions in Tic Suppression". The purpose of this study is to examine how the brain and environment interact to influence children's ability to suppress tics using a medical technology called Transcranial Magnetic Stimulation (TMS).
What is the current status of trial NCT02205918?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-07-01. Estimated completion is 2019-09-01.
What conditions does trial NCT02205918 study?
This clinical trial studies the following conditions: Chronic Motor Tic Disorder, Chronic Vocal Tic Disorder, Tourette's Syndrome.
What interventions are being tested in trial NCT02205918?
The interventions under investigation include: Active TMS (OTHER), Sham TMS (OTHER).
Who is sponsoring clinical trial NCT02205918?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02205918 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Motor Tic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI